The industry’s most established dosage forms, solid dose drugs are shelf stable and easy to administer. But today's drug formulations are complex and high potency, and OSD drugmakers must continue to innovate manufacturing processes if they want to keep up.
In this eBook, you will gain insight on:
Streamlining development of high potency APIs
The future of U.S. generics
A pending titanium dioxide ban
Ensuring tablet integrity
The maturing of continuous manufacturing
This content is sponsored by:
Natoli Enginerring Company
